Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2010, Article ID 250126, 21 pages
http://dx.doi.org/10.1155/2010/250126
Review Article

Coactivators in PPAR-Regulated Gene Expression

1Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
2Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA

Received 11 May 2010; Accepted 1 July 2010

Academic Editor: Yaacov Barak

Copyright © 2010 Navin Viswakarma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. K. Reddy and T. P. Krishnakantha, “Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate,” Science, vol. 190, no. 4216, pp. 787–789, 1975. View at Google Scholar · View at Scopus
  2. J. K. Reddy, M. S. Rao, and D. E. Moody, “Hepatocellular carcinomas in acatalasemic mice treated with Nafenopin, a hypolipidemic peroxisome proliferator,” Cancer Research, vol. 36, no. 4, pp. 1211–1217, 1976. View at Google Scholar · View at Scopus
  3. J. K. Reddy, D. L. Azarnoff, and C. E. Hignite, “Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens,” Nature, vol. 283, no. 5745, pp. 397–398, 1980. View at Google Scholar · View at Scopus
  4. J. K. Reddy, S. K. Goel, and M. R. Nemali, “Transcriptional regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 6, pp. 1747–1751, 1986. View at Google Scholar · View at Scopus
  5. I. Issemann and S. Green, “Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators,” Nature, vol. 347, no. 6294, pp. 645–650, 1990. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Dreyer, G. Krey, H. Keller, F. Givel, G. Helftenbein, and W. Wahli, “Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors,” Cell, vol. 68, no. 5, pp. 879–887, 1992. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Desvergne and W. Wahli, “Peroxisome proliferator-activated receptors: nuclear control of metabolism,” Endocrine Reviews, vol. 20, no. 5, pp. 649–688, 1999. View at Google Scholar · View at Scopus
  8. L. Michalik, J. Auwerx, J. P. Berger et al., “International union of pharmacology. LXI. Peroxisome proliferator-activated receptors,” Pharmacological Reviews, vol. 58, no. 4, pp. 726–741, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. L. Bookout, Y. Jeong, M. Downes, R. T. Yu, R. M. Evans, and D. J. Mangelsdorf, “Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network,” Cell, vol. 126, no. 4, pp. 789–799, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Zhu, C. Qi, J. R. Korenberg et al., “Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPARγ) gene: alternative promoter use and different splicing yield two mPPARγ isoforms,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 17, pp. 7921–7925, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Lazar, “Becoming fat,” Genes and Development, vol. 16, no. 1, pp. 1–5, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Krey, O. Braissant, F. L'Horset et al., “Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay,” Molecular Endocrinology, vol. 11, no. 6, pp. 779–791, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Chawla, J. J. Repa, R. M. Evans, and D. J. Mangelsdorf, “Nuclear receptors and lipid physiology: opening the x-files,” Science, vol. 294, no. 5548, pp. 1866–1870, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Hashimoto, W. S. Cook, C. Qi, A. V. Yeldandi, J. K. Reddy, and M. S. Rao, “Defect in peroxisome proliferator-activated receptor α-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting,” The Journal of Biological Chemistry, vol. 275, no. 37, pp. 28918–28928, 2000. View at Google Scholar · View at Scopus
  15. S. S.-T. Lee, T. Pineau, J. Drago et al., “Targeted disruption of the α isoform of the peroxisome proliferator- activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators,” Molecular and Cellular Biology, vol. 15, no. 6, pp. 3012–3022, 1995. View at Google Scholar · View at Scopus
  16. R. Mukherjee, K. T. Locke, B. Miao et al., “Novel peroxisome proliferator-activated receptor α agonists lower low-density lipoprotein and triglycerides, raise high-density lipoprotein, and synergistically increase cholesterol excretion with a liver X receptor agonist,” Journal of Pharmacology and Experimental Therapeutics, vol. 327, no. 3, pp. 716–726, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. C.-L. Mei, P. He, B. Cheng, W. Liu, Y.-F. Wang, and J.-J. Wan, “Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR α and PPAR γ-dependent pathways,” Cell Biology International, vol. 33, no. 3, pp. 301–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Crisafulli and S. Cuzzocrea, “The role of endogenous and exogenous ligands for the peroxisome proliferator-activated receptor alpha (PPAR-α) in the regulation of inflammation in macrophages,” Shock, vol. 32, no. 1, pp. 62–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S. R. Pyper, N. Viswakarma, S. Yu, and J. K. Reddy, “PPARalpha: energy combustion, hypolipidemia, inflammation and cancer,” Nuclear Receptor Signalling, vol. 16, no. 8, article e002, 2010. View at Google Scholar
  20. J. M. Peters, S. S. T. Lee, W. Li et al., “Growths, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β(δ),” Molecular and Cellular Biology, vol. 20, no. 14, pp. 5119–5128, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. Y.-X. Wang, C.-H. Lee, S. Tiep et al., “Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity,” Cell, vol. 113, no. 2, pp. 159–170, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. L. M. Sanderson, T. Degenhardt, A. Koppen et al., “Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) but not PPARα serves as a plasma free fatty acid sensor in liver,” Molecular and Cellular Biology, vol. 29, no. 23, pp. 6257–6267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. E. D. Rosen and B. M. Spiegelman, “PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth,” The Journal of Biological Chemistry, vol. 276, no. 41, pp. 37731–37734, 2001. View at Google Scholar · View at Scopus
  24. T. Yamauchi, J. Kamon, H. Waki et al., “The mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance,” The Journal of Biological Chemistry, vol. 276, no. 44, pp. 41245–41254, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Tontonoz, E. Hu, and B. M. Spiegelman, “Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor,” Cell, vol. 79, no. 7, pp. 1147–1156, 1994. View at Google Scholar · View at Scopus
  26. S. A. Kliewer, H. E. Xu, M. H. Lambert, and T. M. Willson, “Peroxisome proliferator-activated receptors: from genes to physiology,” Recent Progress in Hormone Research, vol. 56, pp. 239–263, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Yamauchi, J. Kamon, H. Waki et al., “The mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance,” The Journal of Biological Chemistry, vol. 276, no. 44, pp. 41245–41254, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. U. Varanasi, R. Chu, Q. Huang, R. Castellon, A. V. Yeldandi, and J. K. Reddy, “Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene,” The Journal of Biological Chemistry, vol. 271, no. 4, pp. 2147–2155, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Direnzo, M. Söderström, R. Kurokawa et al., “Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors,” Molecular and Cellular Biology, vol. 17, no. 4, pp. 2166–2176, 1997. View at Google Scholar · View at Scopus
  30. V. Chandra, P. Huang, Y. Hamuro et al., “Structure of the intact PPAR-γ-RXR-α nuclear receptor complex on DNA,” Nature, vol. 456, no. 7220, pp. 350–356, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Karagianni and J. Wong, “HDAC3: taking the SMRT-N-CoRrect road to repression,” Oncogene, vol. 26, no. 37, pp. 5439–5449, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Nagy, H.-Y. Kao, D. Chakravarti et al., “Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase,” Cell, vol. 89, no. 3, pp. 373–380, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. L.-N. Wei, X. Hu, D. Chandra, E. Seto, and M. Farooqui, “Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing,” The Journal of Biological Chemistry, vol. 275, no. 52, pp. 40782–40787, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. K. S. Miyata, S. E. McCaw, L. M. Meertens, H. V. Patel, R. A. Rachubinski, and J. P. Capone, “Receptor-interacting protein 140 interacts with and inhibits transactivation by, peroxisome proliferator-activated receptor α and liver- X-receptor α,” Molecular and Cellular Endocrinology, vol. 146, no. 1-2, pp. 69–76, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Debevec, M. Christian, D. Morganstein et al., “Receptor interacting protein 140 regulates expression of uncoupling protein 1 in adipocytes through specific peroxisome proliferator activated receptor isoforms and estrogen-related receptor α,” Molecular Endocrinology, vol. 21, no. 7, pp. 1581–1592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. K. Kang, M. Guermah, C.-X. Yuan, and R. G. Roeder, “The TRAP/mediator coactivator complex interacts directly with estrogen receptors α and β through the TRAP220 subunit and directly enhances estrogen receptor function in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 5, pp. 2642–2647, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. J. W. Conaway, L. Florens, S. Sato et al., “The mammalian Mediator complex,” FEBS Letters, vol. 579, no. 4, pp. 904–908, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Dowell, J. E. Ishmael, D. Avram, V. J. Peterson, D. J. Nevrivy, and M. Leid, “Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor α interacting protein,” The Journal of Biological Chemistry, vol. 274, no. 22, pp. 15901–15907, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. H. E. Xu, M. H. Lambert, V. G. Montana et al., “Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 24, pp. 13919–13924, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. J. D. Chen and R. M. Evans, “A transcriptional co-repressor that interacts with nuclear hormone receptors,” Nature, vol. 377, no. 6548, pp. 454–457, 1995. View at Google Scholar · View at Scopus
  41. R. D. Kornberg, “The molecular basis of eukaryotic transcription,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 32, pp. 12955–12961, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. M. J. Tetel, A. P. Auger, and T. D. Charlier, “Who's in charge? Nuclear receptor coactivator and corepressor function in brain and behavior,” Frontiers in Neuroendocrinology, vol. 30, no. 3, pp. 328–342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. B. W. O'Malley and R. Kumar, “Nuclear receptor coregulators in cancer biology,” Cancer Research, vol. 69, no. 21, pp. 8217–8222, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. D. M. Heery, E. Kalkhoven, S. Hoare, and M. G. Parker, “A signature motif in transcriptional co-activators mediates binding to nuclear receptors,” Nature, vol. 387, no. 6634, pp. 733–736, 1997. View at Publisher · View at Google Scholar · View at Scopus
  45. N. J. McKenna and B. W. O'Malley, “Minireview: nuclear receptor coactivators—an update,” Endocrinology, vol. 143, no. 7, pp. 2461–2465, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. R. G. Roeder, “Transcriptional regulation and the role of diverse coactivators in animal cells,” FEBS Letters, vol. 579, no. 4, pp. 909–915, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. R. P. S. Kwok, J. R. Lundblad, J. C. Chrivia et al., “Nuclear protein CBP is a coactivator for the transcription factor CREB,” Nature, vol. 370, no. 6486, pp. 223–226, 1994. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Chekravarti, V. J. LaMorte, M. C. Nelson et al., “Role of CBP/P300 in nuclear receptor signalling,” Nature, vol. 383, no. 6595, pp. 99–103, 1996. View at Publisher · View at Google Scholar · View at Scopus
  49. R. H. Goodman and S. Smolik, “CBP/p300 in cell growth, transformation, and development,” Genes and Development, vol. 14, no. 13, pp. 1553–1577, 2000. View at Google Scholar · View at Scopus
  50. Z. Wang, C. Qi, A. Krones et al., “Critical roles of the p160 transcriptional coactivators p/CIP and SRC-1 in energy balance,” Cell Metabolism, vol. 3, no. 2, pp. 111–122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. S. A. Onate, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley, “Sequence and characterization of a coactivator for the steroid hormone receptor superfamily,” Science, vol. 270, no. 5240, pp. 1354–1357, 1995. View at Google Scholar · View at Scopus
  52. Y. Zhu, C. Qi, C. Calandra, M. S. Rao, and J. K. Reddy, “Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor gamma,” Gene Expression, vol. 6, no. 3, pp. 185–195, 1996. View at Google Scholar · View at Scopus
  53. H. Hong, K. Kohli, A. Trivedi, D. L. Johnson, and M. R. Stallcup, “GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 10, pp. 4948–4952, 1996. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Li, P. J. Gomes, and J. D. Chen, “RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 16, pp. 8479–8484, 1997. View at Publisher · View at Google Scholar · View at Scopus
  55. S. L. Anzick, J. Kononen, R. L. Walker et al., “AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer,” Science, vol. 277, no. 5328, pp. 965–968, 1997. View at Publisher · View at Google Scholar · View at Scopus
  56. J. C. Chrivia, R. P. S. Kwok, N. Lamb, M. Hagiwara, M. R. Montminy, and R. H. Goodman, “Phosphorylated CREB binds specifically to the nuclear protein CBP,” Nature, vol. 365, no. 6449, pp. 855–859, 1993. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Malik and R. G. Roeder, “Dynamic regulation of pol II transcription by the mammalian Mediator complex,” Trends in Biochemical Sciences, vol. 30, no. 5, pp. 256–263, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. Zhu, C. Qi, S. Jain, M. S. Rao, and J. K. Reddy, “Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor,” The Journal of Biological Chemistry, vol. 272, no. 41, pp. 25500–25506, 1997. View at Publisher · View at Google Scholar · View at Scopus
  59. P. Puigserver, Z. Wu, C. W. Park, R. Graves, M. Wright, and B. M. Spiegelman, “A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis,” Cell, vol. 92, no. 6, pp. 829–839, 1998. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Lin, P. Puigserver, J. Donovan, P. Tarr, and B. M. Spiegelman, “Peroxisome proliferator-activated receptor γ coactivator 1β (PGC-1β), a novel PGC-1-related transcription coactivator associated with host cell factor,” The Journal of Biological Chemistry, vol. 277, no. 3, pp. 1645–1648, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. F. Caira, P. Antonson, M. Pelto-Huikko, E. Treuter, and J.-Å. Gustafsson, “Cloning and characterization of RAP250, a novel nuclear receptor coactivator,” The Journal of Biological Chemistry, vol. 275, no. 8, pp. 5308–5317, 2000. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Zhu, L. Kan, C. Qi et al., “Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR,” The Journal of Biological Chemistry, vol. 275, no. 18, pp. 13510–13516, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Surapureddi, S. Yu, H. Bu et al., “Identification of a transcriptionally active peroxisome proliferator-activated receptor α-interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 18, pp. 11836–11841, 2002. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Surapureddi, N. Viswakarma, S. Yu, D. Guo, M. S. Rao, and J. K. Reddy, “PRIC320, a transcription coactivator, isolated from peroxisome proliferator-binding protein complex,” Biochemical and Biophysical Research Communications, vol. 343, no. 2, pp. 535–543, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. P. B. Becker and W. Hörz, “Atp-dependent nucleosome remodeling,” Annual Review of Biochemistry, vol. 71, pp. 247–273, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. K. E. Neely and J. L. Workman, “The complexity of chromatin remodeling and its links to cancer,” Biochimica et Biophysica Acta, vol. 1603, no. 1, pp. 19–29, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Li, C. Liu, N. Li et al., “Genome-wide coactivation analysis of PGC-1α identifies BAF60a as a regulator of hepatic lipid metabolism,” Cell Metabolism, vol. 8, no. 2, pp. 105–117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. P.-W. Hsiao, C. J. Fryer, K. W. Trotter, W. Wang, and T. K. Archer, “BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation,” Molecular and Cellular Biology, vol. 23, no. 17, pp. 6210–6220, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. M.-B. Debril, L. Gelman, E. Fayard, J.-S. Annicotte, S. Rocchi, and J. Auwerx, “Transcription factors and nuclear receptors interact with the SWI/SNF complex through the BAF60c subunit,” The Journal of Biological Chemistry, vol. 279, no. 16, pp. 16677–16686, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Zhu, C. Qi, W.-Q. Cao, A. V. Yeldandi, M. S. Rao, and J. K. Reddy, “Cloning and characterization of PIMT, a protein with a methyltransferase domain, which interacts with and enhances nuclear receptor coactivator PRIP function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 18, pp. 10380–10385, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. D. Chen, H. Ma, H. Hong et al., “Regulation of transcription by a protein methyltransferase,” Science, vol. 284, no. 5423, pp. 2174–2177, 1999. View at Publisher · View at Google Scholar · View at Scopus
  72. T. Iwasaki, W. W. Chin, and L. Ko, “Identification and characterization of RRM-containing coactivator activator (CoAA) as TRBP-interacting protein, and its splice variant as a coactivator modulator (CoAM),” The Journal of Biological Chemistry, vol. 276, no. 36, pp. 33375–33383, 2001. View at Publisher · View at Google Scholar · View at Scopus
  73. C.-X. Yuan, M. Ito, J. D. Fondell, Z.-Y. Fu, and R. G. Roeder, “The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 14, pp. 7939–7944, 1998. View at Publisher · View at Google Scholar · View at Scopus
  74. C. Rachez, B. D. Lemon, Z. Suldan et al., “Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex,” Nature, vol. 398, no. 6730, pp. 824–828, 1999. View at Publisher · View at Google Scholar · View at Scopus
  75. J. K. Reddy, D. Guo, Y. Jia, S. Yu, and M. S. Rao, “Nuclear receptor transcriptional coactivators in development and metabolism,” Advances in Developmental Biology, vol. 16, pp. 389–420, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Yu and J. K. Reddy, “Transcription coactivators for peroxisome proliferator-activated receptors,” Biochimica et Biophysica Acta, vol. 1771, no. 8, pp. 936–951, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. T.-P. Yao, S. P. Oh, M. Fuchs et al., “Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300,” Cell, vol. 93, no. 3, pp. 361–372, 1998. View at Publisher · View at Google Scholar · View at Scopus
  78. Y. Zhu, C. Qi, Y. Jia, J. S. Nye, M. S. Rao, and J. K. Reddy, “Deletion of PBP/PARBP, the gene for nuclear receptor coactivator peroxisome proliferator-activated receptor-binding protein, results in embryonic lethality,” The Journal of Biological Chemistry, vol. 275, no. 20, pp. 14779–14782, 2000. View at Publisher · View at Google Scholar · View at Scopus
  79. S. E. Crawford, C. Qi, P. Misra et al., “Defects of the heart, eye, and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factors,” The Journal of Biological Chemistry, vol. 277, no. 5, pp. 3585–3592, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. E. L. Clark, A. Coulson, C. Dalgliesh et al., “The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer,” Cancer Research, vol. 68, no. 19, pp. 7938–7946, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. H. Kwon, A. N. Imbalzano, P. A. Khavari, R. E. Kingston, and M. R. Green, “Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complex,” Nature, vol. 370, no. 6489, pp. 477–481, 1994. View at Publisher · View at Google Scholar · View at Scopus
  82. B. M. Spiegelman and R. Heinrich, “Biological control through regulated transcriptional coactivators,” Cell, vol. 119, no. 2, pp. 157–167, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. S.-K. Lee, S. L. Anzick, J.-E. Choi et al., “A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo,” The Journal of Biological Chemistry, vol. 274, no. 48, pp. 34283–34293, 1999. View at Publisher · View at Google Scholar · View at Scopus
  84. M. A. Mahajan and H. H. Samuels, “A new family of nuclear receptor coregulators that integrate nuclear receptor signaling through CREB-binding protein,” Molecular and Cellular Biology, vol. 20, no. 14, pp. 5048–5063, 2000. View at Publisher · View at Google Scholar · View at Scopus
  85. Y.-J. Zhu, S. E. Crawford, V. Stellmach et al., “Coactivator PRIP, the peroxisome proliferator-activated receptor-interacting protein, is a modulator of placental, cardiac, hepatic, and embryonic development,” The Journal of Biological Chemistry, vol. 278, no. 3, pp. 1986–1990, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. D. Li, Q. Kang, and D.-M. Wang, “Constitutive coactivator of peroxisome proliferator-activated receptor (PPARγ), a novel coactivator of PPARγ that promotes adipogenesis,” Molecular Endocrinology, vol. 21, no. 10, pp. 2320–2333, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. G. Zhou, Y. Hashimoto, I. Kwak, S. Y. Tsai, and M.-J. Tsai, “Role of the Steroid Receptor Coactivator SRC-3 in Cell Growth,” Molecular and Cellular Biology, vol. 23, no. 21, pp. 7742–7755, 2003. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Xu, R.-C. Wu, and B. W. O'Malley, “Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family,” Nature Reviews Cancer, vol. 9, no. 9, pp. 615–630, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. H. Zhang, X. Yi, X. Sun et al., “Differential gene regulation by the SRC family of coactivators,” Genes and Development, vol. 18, no. 14, pp. 1753–1765, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. J. Xu, Y. Qiu, F. J. DeMayo, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley, “Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene,” Science, vol. 279, no. 5358, pp. 1922–1925, 1998. View at Publisher · View at Google Scholar · View at Scopus
  91. P. Puigserver, G. Adelmant, Z. Wu et al., “Activation of PPARγ coactivator-1 through transcription factor docking,” Science, vol. 286, no. 5443, pp. 1368–1371, 1999. View at Publisher · View at Google Scholar · View at Scopus
  92. C. Qi, Y. Zhu, J. Pan et al., “Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptor α-regulated gene expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 4, pp. 1585–1590, 1999. View at Publisher · View at Google Scholar · View at Scopus
  93. J. Xu, L. Liao, G. Ning, H. Yoshida-Komiya, C. Deng, and B. W. O'Malley, “The steroid receptor coactivator SRC-3 (P/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 12, pp. 6379–6384, 2000. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Gehin, M. Mark, C. Dennefeld, A. Dierich, H. Gronemeyer, and P. Chambon, “The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP,” Molecular and Cellular Biology, vol. 22, no. 16, pp. 5923–5937, 2002. View at Publisher · View at Google Scholar · View at Scopus
  95. F. Picard, M. Géhin, J.-S. Annicotte et al., “SRC-1 and TIF2 control energy balance between white and brown adipose tissues,” Cell, vol. 111, no. 7, pp. 931–941, 2002. View at Publisher · View at Google Scholar · View at Scopus
  96. R. E. Weiss, J. Xu, G. Ning, J. Pohlenz, B. W. O'Malley, and S. Refetoff, “Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone,” EMBO Journal, vol. 18, no. 7, pp. 1900–1904, 1999. View at Google Scholar · View at Scopus
  97. P. Puigserver, G. Adelmant, Z. Wu et al., “Activation of PPARγ coactivator-1 through transcription factor docking,” Science, vol. 286, no. 5443, pp. 1368–1371, 1999. View at Publisher · View at Google Scholar · View at Scopus
  98. J.-W. Jeong, I. Kwak, K. Y. Lee et al., “The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism,” Molecular Endocrinology, vol. 20, no. 5, pp. 1138–1152, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. A. R. Chopra, J.-F. Louet, P. Saha et al., “Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease,” Science, vol. 322, no. 5906, pp. 1395–1399, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Mark, H. Yoshida-Komiya, M. Gehin et al., “Partially redundant functions of SRC-1 and TIF2 in postnatal survival and male reproduction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 13, pp. 4453–4458, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. J.-F. Louet, A. Coste, L. Amazit et al., “Oncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 47, pp. 17868–17873, 2006. View at Publisher · View at Google Scholar · View at Scopus
  102. J.-F. Louet and B. W. O'Malley, “Coregulators in adipogenesis: what could we learn from the SRC (p160) coactivator family?” Cell Cycle, vol. 6, no. 20, pp. 2448–2452, 2007. View at Google Scholar · View at Scopus
  103. R. Eckner, M. E. Ewen, D. Newsome et al., “Molecular cloning and functional analysis of the adenovirus E1A- associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor,” Genes and Development, vol. 8, no. 8, pp. 869–884, 1994. View at Google Scholar · View at Scopus
  104. D. Chekravarti, V. J. LaMorte, M. C. Nelson et al., “Role of CBP/P300 in nuclear receptor signalling,” Nature, vol. 383, no. 6595, pp. 99–103, 1996. View at Publisher · View at Google Scholar · View at Scopus
  105. Z. Arany, W. R. Sellers, D. M. Livingston, and R. Eckner, “E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators,” Cell, vol. 77, no. 6, pp. 799–800, 1994. View at Publisher · View at Google Scholar · View at Scopus
  106. C. L. Smith, S. A. Oñate, M.-J. Tsai, and B. W. O'Malley, “CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 17, pp. 8884–8888, 1996. View at Publisher · View at Google Scholar · View at Scopus
  107. J. Torchia, D. W. Rose, J. Inostroza et al., “The transcriptional co-activator p/CIP binds CBP and mediates nuclear- receptor function,” Nature, vol. 387, no. 6634, pp. 677–684, 1997. View at Publisher · View at Google Scholar · View at Scopus
  108. L. Waters, B. Yue, V. Veverka et al., “Structural diversity in p160/CREB-binding protein coactivator complexes,” The Journal of Biological Chemistry, vol. 281, no. 21, pp. 14787–14795, 2006. View at Publisher · View at Google Scholar · View at Scopus
  109. A. Polesskaya, I. Naguibneva, A. Duquet, E. Bengal, P. Robin, and A. Harel-Bellan, “Interaction between acetylated MyoD and the bromodomain of CBP and/or p300,” Molecular and Cellular Biology, vol. 21, no. 16, pp. 5312–5320, 2001. View at Publisher · View at Google Scholar · View at Scopus
  110. P. Dowell, J. E. Ishmael, D. Avram, V. J. Peterson, D. J. Nevrivy, and M. Leid, “p300 functions as a coactivator for the peroxisome proliferator- activated receptor α,” The Journal of Biological Chemistry, vol. 272, no. 52, pp. 33435–33443, 1997. View at Publisher · View at Google Scholar · View at Scopus
  111. K. Mochizuki, K. Suruga, N. Sakaguchi, S. Takase, and T. Goda, “Major intestinal coactivator p300 strongly activates peroxisome proliferator-activated receptor in intestinal cell line, Caco-2,” Gene, vol. 291, no. 1-2, pp. 271–277, 2002. View at Publisher · View at Google Scholar · View at Scopus
  112. K. Mochizuki, T. Suzuki, and T. Goda, “PPARα and PPARδ transactivity and p300 binding activity induced by arachidonic acid in colorectal cancer cell line Caco-2,” Journal of Nutritional Science and Vitaminology, vol. 54, no. 4, pp. 298–302, 2008. View at Publisher · View at Google Scholar · View at Scopus
  113. C. Dreyer, H. Keller, A. Mahfoudi, V. Laudet, G. Krey, and W. Wahli, “Positive regulation of the peroxisomal β-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR),” Biology of the Cell, vol. 77, no. 1, pp. 67–76, 1993. View at Google Scholar · View at Scopus
  114. S. A. Kliewer, S. S. Sundseth, S. A. Jones et al., “Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 9, pp. 4318–4323, 1997. View at Publisher · View at Google Scholar · View at Scopus
  115. M. J. Barberá, A. Schlüter, N. Pedraza, R. Iglesias, F. Villarroya, and M. Giralt, “Peroxisome proliferator-activated receptor α activates transcription of the brown fat uncoupling protein-1 gene. A link between regulation of the thermogenic and lipid oxidation pathways in the brown fat cell,” The Journal of Biological Chemistry, vol. 276, no. 2, pp. 1486–1493, 2001. View at Publisher · View at Google Scholar · View at Scopus
  116. L. Gelman, G. Zhou, L. Fajas, E. Raspé, J.-C. Fruchart, and J. Auwerx, “p300 Interacts with the N- and C-terminal part of PPARγ2 in a ligand- independent and -dependent manner, respectively,” The Journal of Biological Chemistry, vol. 274, no. 12, pp. 7681–7688, 1999. View at Publisher · View at Google Scholar · View at Scopus
  117. S. Chen, B. A. Johnson, Y. Li et al., “Both coactivator LXXLL motif-dependent and -independent interactions are required for peroxisome proliferator-activated receptor γ (PPARγ) function,” The Journal of Biological Chemistry, vol. 275, no. 6, pp. 3733–3736, 2000. View at Publisher · View at Google Scholar · View at Scopus
  118. A. Bugge, L. Grøntved, M. M. Aagaard, R. Borup, and S. Mandrup, “The PPARγ2 A/B-domain plays a gene-specific role in transactivation and cofactor recruitment,” Molecular Endocrinology, vol. 23, no. 6, pp. 794–808, 2009. View at Publisher · View at Google Scholar · View at Scopus
  119. J. Mizukami and T. Taniguchi, “The antidiabetic agent thiazolidinedione stimulates the interaction between PPARγ and CBP,” Biochemical and Biophysical Research Communications, vol. 240, no. 1, pp. 61–64, 1997. View at Publisher · View at Google Scholar · View at Scopus
  120. K. Tateishi, Y. Okada, E. M. Kallin, and Y. Zhang, “Role of Jhdm2a in regulating metabolic gene expression and obesity resistance,” Nature, vol. 458, no. 7239, pp. 757–761, 2009. View at Publisher · View at Google Scholar · View at Scopus
  121. C. Qi, S. Surapureddi, Y. -J. Zhu et al., “Transcriptional coactivator PRIP, the peroxisome proliferator-activated receptor γ (PPARγ)-interacting protein, is required for PPARγ-mediated adipogenesis,” The Journal of Biological Chemistry, vol. 278, no. 28, pp. 25281–25284, 2003. View at Publisher · View at Google Scholar · View at Scopus
  122. Y.-M. Sue, C.-P. Chung, H. Lin et al., “PPARδ-mediated p21/p27 induction via increased CREB-binding protein nuclear translocation in beraprost-induced antiproliferation of murine aortic smooth muscle cells,” American Journal of Physiology, vol. 297, no. 2, pp. C321–C329, 2009. View at Publisher · View at Google Scholar · View at Scopus
  123. A. M. Näär, P. A. Beaurang, S. Zhou, S. Abraham, W. Solomon, and R. Tjian, “Composite co-activator ARC mediates chromatin-directed transcriptional activation,” Nature, vol. 398, no. 6730, pp. 828–832, 1999. View at Publisher · View at Google Scholar · View at Scopus
  124. R. D. Kornberg, “Mediator and the mechanism of transcriptional activation,” Trends in Biochemical Sciences, vol. 30, no. 5, pp. 235–239, 2005. View at Publisher · View at Google Scholar · View at Scopus
  125. A. B. Hittelman, D. Burakov, J. A. Iñiguez-Lluhí, L. P. Freedman, and M. J. Garabedian, “Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins,” EMBO Journal, vol. 18, no. 19, pp. 5380–5388, 1999. View at Publisher · View at Google Scholar · View at Scopus
  126. P. Drané, M. Barel, M. Balbo, and R. Frade, “Identification of RB18A, a 205 kDa new p53 regulatory protein which shares antigenic and functional properties with p53,” Oncogene, vol. 15, no. 25, pp. 3013–3024, 1997. View at Google Scholar · View at Scopus
  127. S. Lottin-Divoux, M. Barel, and R. Frade, “RB18A enhances expression of mutant p53 protein in human cells,” FEBS Letters, vol. 579, no. 11, pp. 2323–2326, 2005. View at Publisher · View at Google Scholar · View at Scopus
  128. D. F. Gordon, E. A. Tucker, K. Tundwal, H. Hall, W. M. Wood, and E. C. Ridgway, “MED220/thyroid receptor-associated protein 220 functions as a transcriptional coactivator with pit-1 and GATA-2 on the thyrotropin-β promoter in thyrotropes,” Molecular Endocrinology, vol. 20, no. 5, pp. 1073–1089, 2006. View at Publisher · View at Google Scholar · View at Scopus
  129. H. Li, P. Gade, S. C. Nallar et al., “The Med1 subunit of transcriptional mediator plays a central role in regulating CCAAT/enhancer-binding protein-β-driven transcription in response to interferon-γ,” The Journal of Biological Chemistry, vol. 283, no. 19, pp. 13077–13086, 2008. View at Publisher · View at Google Scholar · View at Scopus
  130. M. Belakavadi and J. D. Fondell, “Role of the Mediator complex in nuclear hormone receptor signaling,” Reviews of Physiology, Biochemistry and Pharmacology, vol. 156, pp. 23–43, 2006. View at Publisher · View at Google Scholar · View at Scopus
  131. P. Misra, E. D. Owuor, W. Li et al., “Phosphorylation of transcriptional coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP). Stimulation of transcriptional regulation by mitogen-activated protein kinase,” The Journal of Biological Chemistry, vol. 277, no. 50, pp. 48745–48754, 2002. View at Publisher · View at Google Scholar · View at Scopus
  132. M. Belakavadi, P. K. Pandey, R. Vijayvargia, and J. D. Fondell, “MED1 phosphorylation promotes its association with mediator: implications for nuclear receptor signaling,” Molecular and Cellular Biology, vol. 28, no. 12, pp. 3932–3942, 2008. View at Publisher · View at Google Scholar · View at Scopus
  133. S. Jain, S. Pulikuri, Y. Zhu et al., “Differential expression of the peroxisome proliferator-activated receptor γ (PPARγ) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse,” American Journal of Pathology, vol. 153, no. 2, pp. 349–354, 1998. View at Google Scholar · View at Scopus
  134. J.-F. Mouillet, T. Chu, D. M. Nelson, T. Mishima, and Y. Sadovsky, “MiR-205 silences MED1 in hypoxic primary human trophoblasts,” FASEB Journal, vol. 24, no. 6, pp. 2030–2039, 2010. View at Publisher · View at Google Scholar · View at Scopus
  135. Y. Barak, M. C. Nelson, E. S. Ong et al., “PPARγ is required for placental, cardiac, and adipose tissue development,” Molecular Cell, vol. 4, no. 4, pp. 585–595, 1999. View at Publisher · View at Google Scholar · View at Scopus
  136. M. Ito, C.-X. Yuan, H. J. Okano, R. B. Darnell, and R. G. Roeder, “Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action,” Molecular Cell, vol. 5, no. 4, pp. 683–693, 2000. View at Google Scholar · View at Scopus
  137. C. Landles, S. Chalk, J. H. Steel et al., “The thyroid hormone receptor-associated protein TRAP220 is required at distinct embryonic stages in placental, cardiac, and hepatic development,” Molecular Endocrinology, vol. 17, no. 12, pp. 2418–2435, 2003. View at Publisher · View at Google Scholar · View at Scopus
  138. K. Ge, Y.-W. Cho, H. Guo et al., “Alternative mechanisms by which mediator subunit MED1/TRAP220 regulates peroxisome proliferator-activated receptor γ-stimulated adipogenesis and target gene expression,” Molecular and Cellular Biology, vol. 28, no. 3, pp. 1081–1091, 2008. View at Publisher · View at Google Scholar · View at Scopus
  139. K. Ge, M. Guermah, C.-X. Yuan et al., “Transcription coactivator TRAP220 is required for PPARγ2-stimulated adipogenesis,” Nature, vol. 417, no. 6888, pp. 563–567, 2002. View at Publisher · View at Google Scholar · View at Scopus
  140. Y. Jia, C. Qi, P. Kashireddi et al., “Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARα-regulated gene expression in liver,” The Journal of Biological Chemistry, vol. 279, no. 23, pp. 24427–24434, 2004. View at Publisher · View at Google Scholar · View at Scopus
  141. W. Chen, X. Zhang, K. Birsoy, and R. G. Roeder, “A muscle-specific knockout implicates nuclear receptor coactivator MED1 in the regulation of glucose and energy metabolism,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 22, pp. 10196–10201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  142. K. Matsumoto, S. Yu, Y. Jia et al., “Critical role for transcription coactivator Peroxisome Proliferator- activated Receptor (PPAR)-binding protein/TRAP220 in liver regeneration and PPARα ligand-induced liver tumor development,” The Journal of Biological Chemistry, vol. 282, no. 23, pp. 17053–17060, 2007. View at Publisher · View at Google Scholar · View at Scopus
  143. K. Matsumoto, J. Huang, N. Viswakarma et al., “Transcription coactivator PBP/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse,” Carcinogenesis, vol. 31, no. 2, pp. 318–325, 2009. View at Publisher · View at Google Scholar · View at Scopus
  144. Y. Jia, G. L. Guo, S. Surapureddi et al., “Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 35, pp. 12531–12536, 2005. View at Publisher · View at Google Scholar · View at Scopus
  145. Y. Jia, N. Viswakarma, T. Fu et al., “Conditional ablation of mediator subunit MED1 (MED1/PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis,” Gene Expression, vol. 14, no. 5, pp. 291–306, 2009. View at Publisher · View at Google Scholar · View at Scopus
  146. Y. Jia, C. Qi, Z. Zhang, Y. T. Zhu, S. M. Rao, and Y.-J. Zhu, “Peroxisome proliferator-activated receptor-binding protein null mutation results in defective mammary gland development,” The Journal of Biological Chemistry, vol. 280, no. 11, pp. 10766–10773, 2005. View at Publisher · View at Google Scholar · View at Scopus
  147. Y. T. Zhu, Y. Jia, L. Hu et al., “Peroxisome-proliferator-activated receptor-binding protein (PBP) is essential for the growth of active Notch4-immortalized mammary epithelial cells by activating SOX10 expression,” Biochemical Journal, vol. 425, no. 2, pp. 435–444, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. A. Kourtidis, R. Jain, R. D. Carkner, C. Eifert, M. J. Brosnan, and D. S. Conklin, “An RNA interference screen identifies metabolic regulators NR1D1 and PBP as novel survival factors for breast cancer cells with the ERBB2 signature,” Cancer Research, vol. 70, no. 5, pp. 1783–1792, 2010. View at Publisher · View at Google Scholar · View at Scopus
  149. R. Vijayvargia, M. S. May, and J. D. Fondell, “A coregulatory role for the mediator complex in prostate cancer cell proliferation and gene expression,” Cancer Research, vol. 67, no. 9, pp. 4034–4041, 2007. View at Publisher · View at Google Scholar · View at Scopus
  150. J. De La Croix Ndong, D. Jean, N. Rousselet, and R. Frade, “Down-regulation of the expression of RB18A/MED1, a cofactor of transcription, triggers strong tumorigenic phenotype of human melanoma cells,” International Journal of Cancer, vol. 124, no. 11, pp. 2597–2606, 2009. View at Publisher · View at Google Scholar · View at Scopus
  151. X. Zhang, A. Krutchinsky, A. Fukuda et al., “MED1/TRAP220 exists predominantly in a TRAP/Mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription,” Molecular Cell, vol. 19, no. 1, pp. 89–100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  152. U. Andersson and R. C. Scarpulla, “PGC-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells,” Molecular and Cellular Biology, vol. 21, no. 11, pp. 3738–3749, 2001. View at Publisher · View at Google Scholar · View at Scopus
  153. J. Lin, P. T. Tarr, R. Yang et al., “PGC-1β in the regulation of hepatic glucose and energy metabolism,” The Journal of Biological Chemistry, vol. 278, no. 33, pp. 30843–30848, 2003. View at Publisher · View at Google Scholar · View at Scopus
  154. R. B. Vega, J. M. Huss, and D. P. Kelly, “The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor α in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes,” Molecular and Cellular Biology, vol. 20, no. 5, pp. 1868–1876, 2000. View at Publisher · View at Google Scholar · View at Scopus
  155. D. Knutti, A. Kaul, and A. Kralli, “A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen,” Molecular and Cellular Biology, vol. 20, no. 7, pp. 2411–2422, 2000. View at Publisher · View at Google Scholar · View at Scopus
  156. Y. Zhang, L. W. Castellani, C. J. Sinal, F. J. Gonzalez, and P. A. Edwards, “Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR,” Genes and Development, vol. 18, no. 2, pp. 157–169, 2004. View at Publisher · View at Google Scholar · View at Scopus
  157. J. Lin, R. Yang, P. T. Tarr et al., “Hyperlipidemic effects of dietary saturated fats mediated through PGC-1β coactivation of SREBP,” Cell, vol. 120, no. 2, pp. 261–273, 2005. View at Publisher · View at Google Scholar · View at Scopus
  158. J. G. Duncan, J. L. Fong, D. M. Medeiros, B. N. Finck, and D. P. Kelly, “Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-α/PGC-1α gene regulatory pathway,” Circulation, vol. 115, no. 7, pp. 909–917, 2007. View at Publisher · View at Google Scholar · View at Scopus
  159. S.-H. Koo, H. Satoh, S. Herzig et al., “PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3,” Nature Medicine, vol. 10, no. 5, pp. 530–534, 2004. View at Publisher · View at Google Scholar · View at Scopus
  160. Y. Li, A. Kovach, K. Suino-Powell, D. Martynowski, and H. E. Xu, “Structural and biochemical basis for the binding selectivity of peroxisome proliferator-activated receptor γ to PGC-1α,” The Journal of Biological Chemistry, vol. 283, no. 27, pp. 19132–19139, 2008. View at Publisher · View at Google Scholar · View at Scopus
  161. E. Hondares, O. Mora, P. Yubero et al., “Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1α gene transcription: an autoregulatory loop controls PGC-1α expression in adipocytes via peroxisome proliferator-activated receptor-γ coactivation,” Endocrinology, vol. 147, no. 6, pp. 2829–2838, 2006. View at Publisher · View at Google Scholar · View at Scopus
  162. T. H. Røst, L. L. Haugan Moi, K. Berge, B. Staels, G. Mellgren, and R. K. Berge, “A pan-PPAR ligand induces hepatic fatty acid oxidation in PPARα/ mice possibly through PGC-1 mediated PPARδ coactivation,” Biochimica et Biophysica Acta, vol. 1791, no. 11, pp. 1076–1083, 2009. View at Publisher · View at Google Scholar · View at Scopus
  163. S. Kleiner, V. Nguyen-Tran, O. Baré, X. Huang, B. Spiegelman, and Z. Wu, “PPARδ agonism activates fatty acid oxidation via PGC-1α but does not increase mitochondrial gene expression and function,” The Journal of Biological Chemistry, vol. 284, no. 28, pp. 18624–18633, 2009. View at Publisher · View at Google Scholar · View at Scopus
  164. T. C. Leone, J. J. Lehman, B. N. Finck et al., “PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis,” PLoS Biology, vol. 3, no. 4, p. e101, 2005. View at Google Scholar · View at Scopus
  165. Z. Arany, H. He, J. Lin et al., “Transcriptional coactivator PGC-1α controls the energy state and contractile function of cardiac muscle,” Cell Metabolism, vol. 1, no. 4, pp. 259–271, 2005. View at Publisher · View at Google Scholar · View at Scopus
  166. J. J. Lehman, S. Boudina, N. H. Banke et al., “The transcriptional coactivator PGC-1α is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis,” American Journal of Physiology, vol. 295, no. 1, pp. H185–H196, 2008. View at Publisher · View at Google Scholar · View at Scopus
  167. C. J. Lelliott, A. Ljungberg, A. Ahnmark et al., “Hepatic PGC-1β overexpression induces combined hyperlipidemia and modulates the response to PPARα activation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 12, pp. 2707–2713, 2007. View at Publisher · View at Google Scholar · View at Scopus
  168. J. Sonoda, I. R. Mehl, L.-W. Chong, R. R. Nofsinger, and R. M. Evans, “PGC-1β controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 12, pp. 5223–5228, 2007. View at Publisher · View at Google Scholar · View at Scopus
  169. Y.-H. Goo, Y. Chang Sohn, D.-H. Kim et al., “Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins,” Molecular and Cellular Biology, vol. 23, no. 1, pp. 140–149, 2003. View at Publisher · View at Google Scholar · View at Scopus
  170. Y. Zhu, C. Qi, S. Jain et al., “Amplication and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 19, pp. 10848–10853, 1999. View at Google Scholar
  171. Y. T. Zhu, L. Hu, C. Qi, and Y.-J. Zhu, “PRIP promotes tumor formation through enhancing serum-responsive factor-mediated FOS expression,” The Journal of Biological Chemistry, vol. 284, no. 21, pp. 14485–14492, 2009. View at Publisher · View at Google Scholar · View at Scopus
  172. S.-W. Kim, K. Park, E. Kwak et al., “Activating signal cointegrator 2 required for liver lipid metabolism mediated by liver X receptors in mice,” Molecular and Cellular Biology, vol. 23, no. 10, pp. 3583–3592, 2003. View at Publisher · View at Google Scholar · View at Scopus
  173. S.-Q. Kuang, L. Liao, H. Zhang et al., “Deletion of the cancer-amplified coactivator AIB3 results in defective placentation and embryonic lethality,” The Journal of Biological Chemistry, vol. 277, no. 47, pp. 45356–45360, 2002. View at Publisher · View at Google Scholar · View at Scopus
  174. Q. Li, M.-J. Chu, and J. Xu, “Tissue- and nuclear receptor-specific function of the C-terminal LXXLL motif of coactivator NCoA6/AIB3 in mice,” Molecular and Cellular Biology, vol. 27, no. 23, pp. 8073–8086, 2007. View at Publisher · View at Google Scholar · View at Scopus
  175. S.-Y. Yeom, G. H. Kim, C. H. Kim et al., “Regulation of insulin secretion and β-cell mass by activating signal cointegrator 2,” Molecular and Cellular Biology, vol. 26, no. 12, pp. 4553–4563, 2006. View at Publisher · View at Google Scholar · View at Scopus
  176. M. A. Mahajan and H. H. Samuels, “Nuclear receptor coactivator/coregulator NCoA6(NRC) is a pleiotropic coregulator involved in transcription, cell survival, growth and development,” Nuclear Receptor Signaling, vol. 6, p. e002, 2008. View at Google Scholar · View at Scopus
  177. H. Zhang, L. Liao, S.-Q. Kuang, and J. Xu, “Spatial distribution of the messenger ribonucleic acid and protein of the nuclear receptor coactivator, amplified in breast cancer-3, in mice,” Endocrinology, vol. 144, no. 4, pp. 1435–1443, 2003. View at Publisher · View at Google Scholar · View at Scopus
  178. P. Antonson, G. U. Schuster, L. Wang et al., “Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction,” Molecular and Cellular Biology, vol. 23, no. 4, pp. 1260–1268, 2003. View at Publisher · View at Google Scholar · View at Scopus
  179. M. A. Mahajan and H. H. Samuels, “Nuclear hormone receptor coregulator: role in hormone action, metabolism, growth, and development,” Endocrine Reviews, vol. 26, no. 4, pp. 583–597, 2005. View at Publisher · View at Google Scholar · View at Scopus
  180. S.-K. Lee, S.-Y. Na, S.-Y. Jung et al., “Activating protein-1, nuclear factor-κB, and serum response factor as novel target molecules of the cancer-amplified transcription coactivator ASC-2,” Molecular Endocrinology, vol. 14, no. 6, pp. 915–925, 2000. View at Publisher · View at Google Scholar · View at Scopus
  181. H. Zhang, S.-Q. Kuang, L. Liao, S. Zhou, and J. Xu, “Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor γ and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice,” Cancer Research, vol. 64, no. 19, pp. 7169–7177, 2004. View at Publisher · View at Google Scholar · View at Scopus
  182. J. Sarkar, C. Qi, D. Guo et al., “Transcription coactivator PRIP, the peroxisome proliferator-activated receptor (PPAR)-interacting protein, is redundant for the function of nuclear receptors PPARα and CAR, the constitutive androstane receptor, in mouse liver,” Gene Expression, vol. 13, no. 4-5, pp. 255–269, 2007. View at Google Scholar · View at Scopus
  183. T. Tomaru, T. Satoh, S. Yoshino et al., “Isolation and characterization of a transcriptional cofactor and its novel isoform that bind the deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-γ,” Endocrinology, vol. 147, no. 1, pp. 377–388, 2006. View at Publisher · View at Google Scholar · View at Scopus
  184. R. S. Savkur and T. P. Burris, “The coactivator LXXLL nuclear receptor recognition motif,” Journal of Peptide Research, vol. 63, no. 3, pp. 207–212, 2004. View at Publisher · View at Google Scholar · View at Scopus
  185. N. Viswakarma, K. Matsumoto, Y. Jia, M. S. Rao, and J. K. Reddy, “Mice lacking transcription cofactor PRIC285 reveal attenuation of liver regeneration but are viable and develop normally,” FASEB Journal, vol. 23, p. 117.6, 2009. View at Google Scholar
  186. I. Shur, R. Socher, and D. Benayahu, “In vivo association of CReMM/CHD9 with promoters in osteogenic cells,” Journal of Cellular Physiology, vol. 207, no. 2, pp. 374–378, 2006. View at Publisher · View at Google Scholar · View at Scopus
  187. C. G. A. Marfella and A. N. Imbalzano, “The Chd family of chromatin remodelers,” Mutation Research, vol. 618, no. 1-2, pp. 30–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  188. J. A. Hall and P. T. Georgel, “CHD proteins: a diverse family with strong ties,” Biochemistry and Cell Biology, vol. 85, no. 4, pp. 463–476, 2007. View at Publisher · View at Google Scholar · View at Scopus
  189. V. Delmas, D. G. Stokes, and R. P. Perry, “A mammalian DNA-binding protein that contains a chromodomain and an SNF2/SW12-like helicase domain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 6, pp. 2414–2418, 1993. View at Google Scholar · View at Scopus
  190. T. Woodage, M. A. Basrai, A. D. Baxevanis, P. Hieter, and F. S. Collins, “Characterization of the CHD family of proteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 21, pp. 11472–11477, 1997. View at Publisher · View at Google Scholar · View at Scopus
  191. I. Shur and D. Benayahu, “Characterization and functional analysis of CReMM, a novel chromodomain helicase DNA-binding protein,” Journal of Molecular Biology, vol. 352, no. 3, pp. 646–655, 2005. View at Publisher · View at Google Scholar · View at Scopus
  192. H. Chiba, M. Muramatsu, A. Nomoto, and H. Kato, “Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor,” Nucleic Acids Research, vol. 22, no. 10, pp. 1815–1820, 1994. View at Google Scholar · View at Scopus
  193. T. Tsukiyama, “The in vivo functions of ATP-dependent chromatin-remodelling factors,” Nature Reviews Molecular Cell Biology, vol. 3, no. 6, pp. 422–429, 2002. View at Publisher · View at Google Scholar · View at Scopus
  194. C. L. Peterson, “Chromatin remodeling: nucleosomes bulging at the seams,” Current Biology, vol. 12, no. 7, pp. R245–R247, 2002. View at Publisher · View at Google Scholar · View at Scopus
  195. T. Å. Pedersen, E. Kowenz-Leutz, A. Leutz, and C. Nerlov, “Cooperation between C/EBPα TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiation,” Genes and Development, vol. 15, no. 23, pp. 3208–3216, 2001. View at Publisher · View at Google Scholar · View at Scopus
  196. B. Lemon, C. Inouye, D. S. King, and R. Tjian, “Selectivity of chromatin-remodelling cofactors for ligand-activated transcription,” Nature, vol. 414, no. 6866, pp. 924–928, 2001. View at Publisher · View at Google Scholar · View at Scopus
  197. N. Salma, H. Xiao, E. Mueller, and A. N. Imbalzano, “Temporal recruitment of transcription factors and SWI/SNF chromatin-remodeling enzymes during adipogenic induction of the peroxisome proliferator-activated receptor γ nuclear hormone receptor,” Molecular and Cellular Biology, vol. 24, no. 11, pp. 4651–4663, 2004. View at Publisher · View at Google Scholar · View at Scopus
  198. W. Wang, J. Côté, Y. Xue et al., “Purification and biochemical heterogeneity of the mammalian SWI-SNF complex,” EMBO Journal, vol. 15, no. 19, pp. 5370–5382, 1996. View at Google Scholar · View at Scopus
  199. Z. Nie, Y. Xue, D. Yang et al., “A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex,” Molecular and Cellular Biology, vol. 20, no. 23, pp. 8879–8888, 2000. View at Publisher · View at Google Scholar · View at Scopus
  200. J. A. Martens and F. Winston, “Recent advances in understanding chromatin remodeling by Swi/Snf complexes,” Current Opinion in Genetics and Development, vol. 13, no. 2, pp. 136–142, 2003. View at Publisher · View at Google Scholar · View at Scopus
  201. P. Misra, C. Qi, S. Yu et al., “Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation,” The Journal of Biological Chemistry, vol. 277, no. 22, pp. 20011–20019, 2002. View at Publisher · View at Google Scholar · View at Scopus
  202. J. Mouaikel, C. Verheggen, E. Bertrand, J. Tazi, and R. Bordonné, “Hypermethylation of the cap structure of both yeast snRNAs and snoRNAs requires a conserved methyltransferase that is localized to the nucleolus,” Molecular Cell, vol. 9, no. 4, pp. 891–901, 2002. View at Publisher · View at Google Scholar · View at Scopus
  203. O. Komonyi, G. Pápai, I. Enunlu et al., “DTL, the Drosophila homolog of PIMT/Tgs1 nuclear receptor coactivator-interacting protein/RNA methyltransferase, has an essential role in development,” The Journal of Biological Chemistry, vol. 280, no. 13, pp. 12397–12404, 2005. View at Publisher · View at Google Scholar · View at Scopus
  204. I. Enünlü, G. Pápai, I. Cserpán, A. Udvardy, K.-T. Jeang, and I. Boros, “Different isoforms of PRIP-interacting protein with methyltransferase domain/trimethylguanosine synthase localizes to the cytoplasm and nucleus,” Biochemical and Biophysical Research Communications, vol. 309, no. 1, pp. 44–51, 2003. View at Publisher · View at Google Scholar · View at Scopus
  205. Y. Jia, N. Viswakarma, K. Matsumoto, S. R. Pyper, M. S. Rao, and J. K. Reddy, “Early embryonic lethality of mice with disrupted transcription cofactor PIMT/NCoA6IP gene,” FASEB Journal, vol. 23, p. 739.6, 2009. View at Google Scholar
  206. M. R. Stallcup, J. H. Kim, C. Teyssier, Y.-H. Lee, H. Ma, and D. Chen, “The roles of protein-protein interactions and protein methylation in transcriptional activation by nuclear receptors and their coactivators,” Journal of Steroid Biochemistry and Molecular Biology, vol. 85, no. 2–5, pp. 139–145, 2003. View at Publisher · View at Google Scholar · View at Scopus
  207. J. M. Aletta, T. R. Cimato, and M. J. Ettinger, “Protein methylation: a signal event in post-translational modification,” Trends in Biochemical Sciences, vol. 23, no. 3, pp. 89–91, 1998. View at Publisher · View at Google Scholar · View at Scopus
  208. N. Yadav, D. Cheng, S. Richard et al., “CARM1 promotes adipocyte differentiation by coactivating PPARγ,” EMBO Reports, vol. 9, no. 2, pp. 193–198, 2008. View at Publisher · View at Google Scholar · View at Scopus
  209. M. Chevillard-Briet, D. Trouche, and L. Vandel, “Control of CBP co-activating activity by arginine methylation,” EMBO Journal, vol. 21, no. 20, pp. 5457–5466, 2002. View at Publisher · View at Google Scholar · View at Scopus
  210. W. Xu, H. Chen, K. Du et al., “A transcriptional switch mediated by cofactor methylation,” Science, vol. 294, no. 5551, pp. 2507–2511, 2001. View at Publisher · View at Google Scholar · View at Scopus
  211. Y.-H. Lee, S. A. Coonrod, W. L. Kraus, M. A. Jelinek, and M. R. Stallcup, “Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 10, pp. 3611–3616, 2005. View at Publisher · View at Google Scholar · View at Scopus
  212. C. Teyssier, D. Chen, and M. R. Stallcup, “Requirement for multiple domains of the protein arginine methyltransferase CARM1 in its transcriptional coactivator function,” The Journal of Biological Chemistry, vol. 277, no. 48, pp. 46066–46072, 2002. View at Publisher · View at Google Scholar · View at Scopus
  213. M. T. Bedford, “Arginine methylation at a glance,” Journal of Cell Science, vol. 120, no. 24, pp. 4243–4246, 2007. View at Publisher · View at Google Scholar · View at Scopus
  214. Q. Feng, P. Yi, J. Wong, and B. W. O'Malley, “Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly,” Molecular and Cellular Biology, vol. 26, no. 21, pp. 7846–7857, 2006. View at Publisher · View at Google Scholar · View at Scopus
  215. N. Yadav, J. Lee, J. Kim et al., “Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 11, pp. 6464–6468, 2003. View at Publisher · View at Google Scholar · View at Scopus
  216. D. Auboeuf, D. H. Dowhan, X. Li et al., “CoAA, a nuclear receptor coactivator protein at the interface of transcriptional coactivation and RNA splicing,” Molecular and Cellular Biology, vol. 24, no. 1, pp. 442–453, 2004. View at Publisher · View at Google Scholar · View at Scopus
  217. S. Y. Jung, A. Malovannaya, J. Wei, B. W. O'Malley, and J. Qin, “Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes,” Molecular Endocrinology, vol. 19, no. 10, pp. 2451–2465, 2005. View at Publisher · View at Google Scholar · View at Scopus
  218. D. M. Lonard, R. B. Lanz, and B. W. O'Malley, “Nuclear receptor coregulators and human disease,” Endocrine Reviews, vol. 28, no. 5, pp. 575–587, 2007. View at Publisher · View at Google Scholar · View at Scopus